Physician profile
Alexander E Morf
NPI 1932485281
$9,125.81
in general payments reported to CMS, 2019-2025
41 companies · $1,441 in 2025
The $1,441 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,171 · 2020: $1,087 · 2021: $1,548 · 2022: $1,423 · 2023: $1,282 · 2024: $1,174 · 2025: $1,441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,896.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,274.80 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $1,252.08 | 2021-2025 | |
| Novo Nordisk INC | $1,012.00 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $941.57 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $550.52 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $481.90 | 2019-2025 | Jardiance, Synjardy |
| Lilly USA, LLC | $370.11 | 2019-2025 | Mounjaro, Zepbound |
| Bayer Healthcare Pharmaceuticals INC. | $295.32 | 2022-2025 | |
| Glaxosmithkline, LLC. | $252.35 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Nestle Healthcare Nutrition INC. | $240.92 | 2021-2023 | |
| Amgen INC. | $224.31 | 2019-2025 | Evenity, Prolia, Prolia |
| Portola Pharmaceuticals, LLC | $199.55 | 2019-2020 | |
| Amarin Pharma, INC. | $189.57 | 2019-2021 | |
| Astellas Pharma US INC | $188.24 | 2019-2025 | Veozah |
| Exact Sciences Corporation | $183.03 | 2023-2025 | Cologuard Collection Kit |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Morf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.